ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024
Erratum: Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.